Mineralocorticoid Antagonism to Stop Progression of Atrial Fibrillation (MONITOR-AF) Study

NCT04327232 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

184

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Spironolactone 25mg
DRUG: Placebo oral tablet

Sponsor

National University Hospital, Singapore

Collaborators

[object Object]